Peter Huntsman speaking at HCIFOR OUR FAMILY, 2017 at Huntsman Cancer Institute (HCI) was nothing short of spectacular. We realized our dream to speed the development of better treatments with the dedication of the new Primary Children’s and Families’ Cancer Research Center on June 21, 2017. The new 225,000-square-foot building brings more resources to fight this dreaded disease, it doubles the laboratory research space, and it expands services to help families overcome cancer.

Since the founding of HCI, the pace of work, the rate of building, and the new treatment advancements achieved have been breathtaking. Every recipient of this report has helped make this possible. We are very grateful to each of you for sharing our passion to end the suffering caused by cancer. In all, more than 1 million people have donated to this effort. Thank you!

Our family’s motto is, “Cancer moves fast. And we have to move faster.” With that in mind, HCI has announced plans to add proton therapy to its arsenal of treatment technologies. Proton therapy delivers beams of radiation to shrink a tumor. It has proven to be an effective option for numerous childhood and adult cancers, including head, neck, and brain tumors, lymphomas, and pancreas, prostate, and esophageal cancers. Proton therapy is often the favored course of treatment when a tumor is close to a vital structure such as the spinal cord or brain. The equipment is very expensive—approximately $30 million. Huntsman Cancer Foundation will contribute $10 million toward the cost to make this treatment possible. Right now, the nearest places to receive proton therapy are Los Angeles and Tucson. HCI’s plan to add proton therapy illustrates that we will never rest on our laurels or previously earned accolades.

Speaking of accolades, our CEO and Director, Mary Beckerle, PhD, is the 2018 recipient of the prestigious Alfred G. Knudson Award in Cancer Genetics from the National Cancer Institute. The award has been presented for the past 22 years to the person who has made the greatest contributions to the cancer genetics field. Past recipients include four Nobel Laureates. To say we are proud of Dr. Beckerle is an understatement. With an accomplished leader like her, you can be assured that your support is in the hands of an excellent steward and exceptional leader.

We promise you that we will not rest until cancer is eradicated from the face of the earth. Each generation of our family is steadfast in this promise to our friends, neighbors, fellow citizens of Utah, the Mountain West, the United States, and the international community. That is why we have pledged to add $120 million in support over the next eight years.

The successful performance of Huntsman Corporation stock we donated years ago provides strong financial footing for HCI’s future. It means other donations can go directly to research and care, instead of paying for overhead and administrative costs. One donor alone is not solely responsible for the success of HCI. Every donor, member of our fine Huntsman Cancer Foundation team, and of course, our skilled researchers, physicians, and staff at HCI must be thanked for the progress we have made.

Together, we are making spectacular things happen at HCI. We are very grateful.

Read more highlights from a remarkable year of accomplishment at HCI in our 2018 Report to the Community.

annual report cover. click to read more stories from the 2018 Report to Our Community